Top Suppliers:I want be here


2055404-90-3

2055404-90-3 structure
2055404-90-3 structure
  • Name: Hexokinase 2 modulator Comp-1
  • Chemical Name: Tuvatexib
  • CAS Number: 2055404-90-3
  • Molecular Formula: C21H23NO3
  • Molecular Weight: 337.419
  • Catalog: Research Areas Cancer
  • Create Date: 2020-01-11 17:59:41
  • Modify Date: 2024-10-03 19:17:12
  • Tuvatexib (Hexokinase 2 modulator Comp-1) is a potent, selective small molecule modulator of Hexokinase 2 (HK2) interaction with the mitochondria, selectively dissociates HK2 from VDAC1 in vitro with IC50 of 92 nM; does not affect the VDAC1/HK1 complex; dose-dependent reduces mitochondrial-bound HK2 levels in human skin SCC A431 cells with IC50 of 0.8 uM, reduces glycolysis and triggers apoptosis in cancer cells, without affecting hexokinase 1-expressing normal cells; demonstrates anti-cancer activity in UVB-damaged skin model in SKH-1 mice.

Name Tuvatexib
Description Tuvatexib (Hexokinase 2 modulator Comp-1) is a potent, selective small molecule modulator of Hexokinase 2 (HK2) interaction with the mitochondria, selectively dissociates HK2 from VDAC1 in vitro with IC50 of 92 nM; does not affect the VDAC1/HK1 complex; dose-dependent reduces mitochondrial-bound HK2 levels in human skin SCC A431 cells with IC50 of 0.8 uM, reduces glycolysis and triggers apoptosis in cancer cells, without affecting hexokinase 1-expressing normal cells; demonstrates anti-cancer activity in UVB-damaged skin model in SKH-1 mice.
References References 1. Behar V, et al. J Invest Dermatol. 2018 Jun 14. pii: S0022-202X(18)32056-6. 2. Goldin N, et al. Oncogene. 2008 Aug 7;27(34):4636-43. 3. Krasnov GS, et al. Expert Opin Ther Targets. 2013 Oct;17(10):1221-33. 4. PCT Int. Appl. (2018), WO 2018083705 A1 20180511. View Related Products by Target Hexokinase
Molecular Formula C21H23NO3
Molecular Weight 337.419
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.